Obsessive-Compulsive Disorder

Download PDF

Recent Publications on Obsessive-Compulsive Disorder:
Are neuropsychological deficits trait markers in OCD? OBJECTIVE: Neuropsychological deficits are potential endophenotype...	28th June, 2008	Department of Psychiatry, National Institute of Mental Health and	Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jun 8;. DOI Direct Link
Comorbidity of conduct disorder and bipolar disorder in clinically referred children and adolescents. Abstract Objective: The co-occurrence of conduct disorder (CD) and bipolar...	28th June, 2008	IRCCS Stella Maris, Scientific Institute of Child Neurology and	J Child Adolesc Psychopharmacol. 2008 Jun;18(3):271-9. DOI Direct Link
New-onset psychiatric disorders in individuals with autism. A follow-up study to at least the age of 21 years of 135 individuals with...	27th June, 2008	Institute	Autism. 2008 Jul;12(4):373-90. DOI Direct Link
Neurocognitive profile analysis in obsessive-compulsive disorder. Although neurocognitive deficits have been identified in...	26th June, 2008	Division of Psychiatry Research, The Zucker Hillside Hospital, North	J Int Neuropsychol Soc. 2008 Jul;14(4):640-5. DOI Direct Link
Psychiatric disorders related to menstrual bleeding among an ultra-orthodox population: case series and literature review. The relationship between menstrual cycle and obsessive-compulsive disorder...	26th June, 2008	Beer-Yaacov Ness-Ziona Mental Health Center, Ness-Ziona, Israel.	Int J Soc Psychiatry. 2008 May;54(3):219-24.
→View more research publications.

BioNews Results for Obsessive-Compulsive Disorder:
New treatment for Obsessive Compulsive Disorder	News-Medical.Net:  Jun 16 2008 4:45AM Matching: obsessive compulsive disorder
TopAbstracts in Anxiety 06/11/2008	Doctors Guide:  Jun 13 2008 4:50AM Matching: obsessive compulsive disorder
BioMedEcon Reports 200% Higher Outpatient Medical Costs among Patients with Obsessive-Compulsive Disorder Comp	Therapeutics Daily:  Jun 12 2008 3:09PM Matching: obsessive compulsive disorder
BioMedEcon Reports 200% Higher Outpatient Medical Costs among Patients with Obsessive-Compulsive Disorder Comp	Pharma Live:  Jun 12 2008 2:44PM Matching: obsessive compulsive disorder
BioMedEcon Reports 200% Higher Outpatient Medical Costs among Patients with Obsessive-Compulsive Disorder Comp	Genetic Engineering News:  Jun 12 2008 2:11PM Matching: obsessive compulsive disorder
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Obsessive-Compulsive Disorder Clinical Trials:
Serotonin Transporters in Obsessive-Compulsive-Related Disorders	Obsessive-Compulsive Disorder
Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study	Obsessive Compulsive Disorder
Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)	Obsessive Compulsive Disorder
Quetiapine Augmentation in Severe Obsessive Compulsive Disorder	Obsessive Compulsive Disorder
Cognitive-Behavioral Bibliotherapy for the Treatment of Obsessive Compulsive Disorder in Children and Adolescents	Obsessive-Compulsive Disorder
→View more trials.

Obsessive-Compulsive Disorder Patents:
US Patent No.	Title
7320994	Triazole derivatives as tachykinin receptor antagonists
7345019	Modulation of excitable tissue function by peripherally administered erythropoietin
7345038	Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
7345077	4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
7345083	Hydroisoindoline tachykinin receptor antagonists
→View more patents.

Companies working in the area of Obsessive-Compulsive Disorder from Bioportfolio's Biocorporate database :
Company Name
Clinical Insights Clinical Insights was established in 1996 as an independent clinical trial center specializing in Phase II, III, and IV psychopharmacological research. The mission of Clinical Insights is to become... www.clinicalinsights.com/        View full profile
Clinical Insights Clinical Insights was established in 1996 as an independent clinical trial center specializing in Phase II, III, and IV psychopharmacological research. The mission of Clinical Insights is to become... www.clinicalinsights.com/        View full profile
Zoloft Zoloft is well tolerated and effective for the treatment of depression and certain types of anxiety disorders. Zoloft is FDA approved to treat depression, social anxiety disorder, posttraumatic stress... www.zoloft.com/        View full profile
→View more Obsessive-Compulsive Disorder related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Obsessive-Compulsive Disorder scientists - we have details of around 933 individuals working on Obsessive-Compulsive Disorder .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.